AKT inhibitors have been used therapeutically for several other cancers due to AKT’s significance in activating mTOR, specifically mTOR complex 1 (mTORC1), which plays a significant role in cell metabolism and anabolism [60, 69]. Here, AKT1 is linked to cancer.